InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

Sight Sciences, Inc.

SGHT Clue Score46
United States Fiscal year ends December CIK 0001531177 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Staffan Encrantz
10 Jun 2026
Director
Buy
14,100
$4.88
$68.79K
Staffan Encrantz
16 Dec 2025
Director
Buy
13,958
$8.31
$115.96K
Staffan Encrantz
6 Jun 2025
Director
Buy
27,900
$4.22
$117.74K
Staffan Encrantz
5 Jun 2025
Director
Buy
40,951
$4.24
$173.80K
Staffan Encrantz
4 Jun 2025
Director
Buy
21,674
$4.17
$90.42K
Staffan Encrantz
3 Jun 2025
Director
Buy
25,230
$3.97
$100.09K
Staffan Encrantz
2 Jun 2025
Director
Buy
30,799
$3.88
$119.44K
Staffan Encrantz
30 May 2025
Director
Buy
42,753
$3.67
$156.90K
Staffan Encrantz
29 May 2025
Director
Buy
60,128
$3.59
$215.74K
Staffan Encrantz
28 May 2025
Director
Buy
26,715
$3.52
$93.93K
Staffan Encrantz
27 May 2025
Director
Buy
41,346
$3.44
$142.06K
Manohar K. Raheja
13 Mar 2025
EVP, Research & Development
Buy
10,000
$2.60
$26.00K
Manohar K. Raheja
12 Mar 2025
EVP, Research & Development
Buy
10,000
$2.73
$27.25K
Manohar K. Raheja
6 Dec 2024
EVP, Research & Development
Buy
5,000
$3.85
$19.25K
Manohar K. Raheja
3 Dec 2024
EVP, Research & Development
Buy
3,376
$3.89
$13.13K
Manohar K. Raheja
29 Nov 2024
EVP, Research & Development
Buy
4,624
$3.99
$18.44K
Staffan Encrantz
21 Nov 2024
Director
Buy indirect
551,802
$3.73
$2.06M
Manohar K. Raheja
19 Nov 2024
EVP, Research & Development
Buy
2,000
$3.70
$7.40K
Staffan Encrantz
30 Nov 2023
Director
Buy
140,777
$3.46
$486.64K
Staffan Encrantz
29 Nov 2023
Director
Buy
3,223
$3.50
$11.28K
Staffan Encrantz
28 Nov 2023
Director
Buy
253,669
$3.46
$877.14K
Staffan Encrantz
27 Nov 2023
Director
Buy
246,331
$3.31
$815.95K
Staffan Encrantz
24 Nov 2023
Director
Buy
21,855
$3.09
$67.43K
Staffan Encrantz
22 Nov 2023
Director
Buy
41,085
$2.50
$102.71K
Staffan Encrantz
21 Nov 2023
Director
Buy
68,477
$2.48
$169.54K
Staffan Encrantz
20 Nov 2023
Director
Buy
79,234
$2.25
$178.19K
Staffan Encrantz
17 Nov 2023
Director
Buy
126,664
$2.19
$277.29K
Staffan Encrantz
16 Nov 2023
Director
Buy
339
$2.00
$678.00
Staffan Encrantz
14 Nov 2023
Director
Buy
3,462
$2.00
$6.91K
Staffan Encrantz
17 May 2022
Director
Buy indirect
250,000
$8.49
$2.12M
Staffan Encrantz
16 May 2022
Director
Buy indirect
300,000
$8.20
$2.46M
Jesse Selnick
13 May 2022
Chief Financial Officer
Buy
5,000
$8.28
$41.40K
Staffan Encrantz
13 May 2022
Director
Buy indirect
1,802
$7.98
$14.38K
Staffan Encrantz
1 Dec 2021
Director
Buy indirect
62,959
$22.92
$1.44M
Staffan Encrantz
1 Dec 2021
Director
Buy indirect
123,931
$22.36
$2.77M
Staffan Encrantz
1 Dec 2021
Director
Buy indirect
27,716
$21.43
$593.95K
Staffan Encrantz
30 Nov 2021
Director
Buy indirect
56,836
$20.96
$1.19M
Staffan Encrantz
30 Nov 2021
Director
Buy indirect
94,969
$20.40
$1.94M
Staffan Encrantz
30 Nov 2021
Director
Buy indirect
72,135
$19.44
$1.40M
Staffan Encrantz
29 Nov 2021
Director
Buy indirect
2,200
$19.06
$41.93K
Staffan Encrantz
29 Nov 2021
Director
Buy indirect
84,254
$18.84
$1.59M
Jesse Selnick
23 Nov 2021
Chief Financial Officer
Buy indirect
10,000
$18.44
$184.39K
Staffan Encrantz
18 Oct 2021
Director
Buy indirect
527,048
$24.00
$12.65M
D1 Capital Partners L.P.
19 Jul 2021
10% owner
Buy indirect
700,000
$24.00
$16.80M
Show all 144 transactions →

What was left out

Form 4 filings counted 198
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 24
Sales straight out of an exercise 2
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 33,312,093
History held since 16 Jul 2021